Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells

Molecular Metabolism

Volumn 6, Issue 8, 2017, Pages 819-832

  Fletcher, Rachel S ^a,b   Ratajczak, Joanna ^c,d   Doig, Craig L ^a,b   Oakey, Lucy A ^b   Callingham, Rebecca ^e   Da Silva Xavier, Gabriella ^e   Garten, Antje ^a,f   Elhassan, Yasir S ^a,b   Redpath, Philip ^g   Migaud, Marie E ^g   Philp, Andrew ^a   Brenner, Charles ^h   Canto, Carles ^c,d   Lavery, Gareth G ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Birmingham Women s Hospital NHS Foundation Trust   (United Kingdom)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

^d EPFL   (Switzerland)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g USA Mitchell Cancer Institute   (United States)

^h UNIVERSITY OF IOWA   (United States)

Author keywords

Energy metabolism; NAD+; Nicotinamide riboside; Skeletal muscle

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NICOTINAMIDE RIBOSIDE; NICOTINAMIDE RIBOSIDE KINASE 1; NICOTINAMIDE RIBOSIDE KINASE 2; UNCLASSIFIED DRUG; CYTOKINE; NICOTINAMIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, MOUSE; NICOTINAMIDE-BETA-RIBOSIDE; NMRK1 PROTEIN, MOUSE; PHOSPHOTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CELL METABOLISM; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HOMEOSTASIS; METABOLOME; MOUSE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE CELL; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; FEMALE; GENETICS; MALE; METABOLISM;

ANIMALS; CELL LINE; CELLS, CULTURED; CYTOKINES; FEMALE; MALE; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; NIACINAMIDE; NICOTINAMIDE MONONUCLEOTIDE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EID: 85020386967     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2017.05.011     Document Type: Article

References (67)

1. Belenky, P., Bogan, K.L., Brenner, C., NAD+ metabolism in health and disease. Trends in Biochemical Sciences 32:1 (2007), 12–19.
2. Bogan, K.L., Brenner, C., Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annual Review of Nutrition 28:1 (2008), 115–130.
3. Mouchiroud, Laurent, Houtkooper, Riekelt H., Moullan, Norman, Katsyuba, Elena, Ryu, Dongryeol, Cantó, Carles, et al. The NAD+/sirtuin pathway modulates longevity through activation of mitochondrial UPR and FOXO signaling. Cell 154:2 (2013), 430–441.
4. Amat, R., Planavila, A., Chen, S.L., Iglesias, R., Giralt, M., Villarroya, F., SIRT1 controls the transcription of the peroxisome proliferator-activated receptor-gamma Co-activator-1alpha (PGC-1alpha) gene in skeletal muscle through the PGC-1alpha autoregulatory loop and interaction with MyoD. Journal of Biological Chemistry 284:33 (2009), 21872–21880.
5. Canto, C., Jiang, L.Q., Deshmukh, A.S., Mataki, C., Coste, A., Lagouge, M., et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metabolism 11:3 (2010), 213–219.
6. Hood, D.A., Irrcher, I., Ljubicic, V., Joseph, A.-M., Coordination of metabolic plasticity in skeletal muscle. Journal of Experimental Biology 209:12 (2006), 2265–2275.
7. Koltai, E., Szabo, Z., Atalay, M., Boldogh, I., Naito, H., Goto, S., et al. Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mechanisms of Ageing and Development 131:1 (2010), 21–28.
8. Egan, B., Zierath, Juleen R., Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metabolism 17:2 (2013), 162–184.
9. Preiss, J., Handler, P., Biosynthesis of diphosphopyridine nucleotide: I. Identification of intermediates. Journal of Biological Chemistry 233:2 (1958), 488–492.
10. Preiss, J., Handler, P., Biosynthesis of diphosphopyridine nucleotide: II. Enzymatic aspects. Journal of Biological Chemistry 233:2 (1958), 493–500.
11. Garten, A., Petzold, S., Körner, A., Imai, S-i, Kiess, W., Nampt: linking NAD biology, metabolism and cancer. Trends in Endocrinology & Metabolism 20:3 (2009), 130–138.
12. Bieganowski, P., Brenner, C., Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell 117:4 (2004), 495–502.
13. +. PLoS Biology, 5(10), 2007, e263.
14. Gille, A., Bodor, E.T., Ahmed, K., Offermanns, S., Nicotinic acid: pharmacological effects and mechanisms of action. Annual Review of Pharmacology and Toxicology 48:1 (2008), 79–106.
15. van de Weijer, T., Phielix, E., Bilet, L., Williams, E.G., Ropelle, E.R., Bierwagen, A., et al. Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans. Diabetes 64:4 (2015), 1193–1201.
16. Revollo, J.R., Grimm, A.A., Imai, S.-i., The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. Journal of Biological Chemistry 279:49 (2004), 50754–50763.
17. Zarzuelo, M.J., López-Sepúlveda, R., Sánchez, M., Romero, M., Gómez-Guzmán, M., Ungvary, Z., et al. SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging. Biochemical Pharmacology 85:9 (2013), 1288–1296.
18. MacKay, D., Hathcock, J., Guarneri, E., Niacin: chemical forms, bioavailability, and health effects. Nutrition Reviews 70:6 (2012), 357–366.
19. Yoshino, J., Mills, K.F., Yoon, M.J., Imai, S., Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metabolism 14:4 (2011), 528–536.
20. Mendelsohn, A.R., Larrick, J.W., Partial reversal of skeletal muscle aging by restoration of normal NAD(+) levels. Rejuvenation Research 17:1 (2014), 62–69.
21. Gomes, A.P., Price, N.L., Ling, A.J., Moslehi, J.J., Montgomery, M.K., Rajman, L., et al. Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155:7 (2013), 1624–1638.
22. Cantó, C., Houtkooper Riekelt, H., Pirinen, E., Youn Dou, Y., Oosterveer Maaike, H., Cen, Y., et al. The NAD+ precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metabolism 15:6 (2012), 838–847.
23. Khan, N.A., Auranen, M., Paetau, I., Pirinen, E., Euro, L., Forsstrom, S., et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Molecular Medicine 6:6 (2014), 721–731.
24. Hamity, M.V., White, S.R., Walder, R.Y., Schmidt, M.S., Brenner, C., Hammond, D.L., Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats. Pain 158:5 (2017), 962–972.
25. Trammell, S.A., Weidemann, B.J., Chadda, A., Yorek, M.S., Holmes, A., Coppey, L.J., et al. Nicotinamide riboside opposes type 2 diabetes and neuropathy in mice. Science Reports, 6, 2016, 26933.
26. Trammell, S.A., Schmidt, M.S., Weidemann, B.J., Redpath, P., Jaksch, F., Dellinger, R.W., et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications, 7, 2016, 12948.
27. Trammell, S.A., Yu, L., Redpath, P., Migaud, M.E., Brenner, C., Nicotinamide riboside is a major NAD+ precursor vitamin in cow milk. Journal of Nutrition 146:5 (2016), 957–963.
28. Ratajczak, J., Joffraud, M., Trammell, S.A., Ras, R., Canela, N., Boutant, M., et al. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nature Communications, 7, 2016, 13103.
29. Kammoun, M., Cassar-Malek, I., Meunier, B., Picard, B., A simplified immunohistochemical classification of skeletal muscle fibres in mouse. European Journal of Histochemistry, 58(2), 2014, 2254.
30. Sawano, S., Komiya, Y., Ichitsubo, R., Ohkawa, Y., Nakamura, M., Tatsumi, R., et al. A one-step immunostaining method to visualize rodent muscle fiber type within a single specimen. PLoS One, 11(11), 2016.
31. Bloemberg, D., Quadrilatero, J., Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis. PLoS One, 7(4), 2012, e35273.
32. Penke, M., Larsen, P.S., Schuster, S., Dall, M., Jensen, B.A.H., Gorski, T., et al. Hepatic NAD salvage pathway is enhanced in mice on a high-fat diet. Molecular and Cellular Endocrinology 412 (2015), 65–72.
33. Trammell, S.A., Brenner, C., Targeted, LCMS-based metabolomics for quantitative measurement of NAD(+) metabolites. Computational and Structural Biotechnology Journal, 4, 2013, e201301012.
34. Mori, V., Amici, A., Mazzola, F., Di Stefano, M., Conforti, L., Magni, G., et al. Metabolic profiling of alternative NAD biosynthetic routes in mouse tissues. PLoS One, 9(11), 2014, e113939.
35. Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., McNiece, I., Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Molecular and Cellular Biology 14:2 (1994), 1431–1437.
36. Hara, N., Yamada, K., Terashima, M., Osago, H., Shimoyama, M., Tsuchiya, M., Molecular identification of human glutamine- and ammonia-dependent NAD synthetases. Carbon-nitrogen hydrolase domain confers glutamine dependency. Journal of Biological Chemistry 278:13 (2003), 10914–10921.
37. Lavery, G.G., Walker, E.A., Turan, N., Rogoff, D., Ryder, J.W., Shelton, J.M., et al. Deletion of Hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy. Journal of Biological Chemistry 283:13 (2008), 8453–8461.
38. Frederick, D.W., Loro, E., Liu, L., Davila, A. Jr., Chellappa, K., Silverman, I.M., et al. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metabolism 24:2 (2016), 269–282.
39. Kim, J.S., Yoon, C.S., Park, D.R., NAMPT regulates mitochondria biogenesis via NAD metabolism and calcium binding proteins during skeletal muscle contraction. Journal of Exercise Nutrition & Biochemistry 18:3 (2014), 259–266.
40. Kulikova, V., Shabalin, K., Nerinovski, K., Dolle, C., Niere, M., Yakimov, A., et al. Generation, release, and uptake of the NAD precursor nicotinic acid riboside by human cells. Journal of Biological Chemistry 290:45 (2015), 27124–27137.
41. Bieganowski, P., Pace, H.C., Brenner, C., Eukaryotic NAD+ synthetase Qns1 contains an essential, obligate intramolecular thiol glutamine amidotransferase domain related to nitrilase. Journal of Biological Chemistry 278:35 (2003), 33049–33055.
42. Hasmann, M., Schemainda, I., FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Research 63:21 (2003), 7436–7442.
43. Fulco, M., Cen, Y., Zhao, P., Hoffman, E.P., McBurney, M.W., Sauve, A.A., et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Developmental Cell 14:5 (2008), 661–673.
44. Schuster, S., Penke, M., Gorski, T., Gebhardt, R., Weiss, T.S., Kiess, W., et al. FK866-induced NAMPT inhibition activates AMPK and downregulates mTOR signaling in hepatocarcinoma cells. Biochemical and Biophysical Research Communications 458:2 (2015), 334–340.
45. Belenky, P., Christensen, K.C., Gazzaniga, F., Pletnev, A.A., Brenner, C., Nicotinamide riboside and nicotinic acid riboside salvage in fungi and mammals. Quantitative basis for Urh1 and purine nucleoside phosphorylase function in NAD+ metabolism. Journal of Biological Chemistry 284:1 (2009), 158–164.
46. Ishihara, K., Hirano, T., BST-1/CD157 regulates the humoral immune responses in vivo. Chemical Immunology 75 (2000), 235–255.
47. Uddin, G.M., Youngson, N.A., Sinclair, D.A., Morris, M.J., Head to head comparison of short-term treatment with the NAD(+) precursor nicotinamide mononucleotide (NMN) and 6 weeks of exercise in obese female mice. Frontiers in Pharmacology, 7, 2016, 258.
48. de Picciotto, N.E., Gano, L.B., Johnson, L.C., Martens, C.R., Sindler, A.L., Mills, K.F., et al. Nicotinamide mononucleotide supplementation reverses vascular dysfunction and oxidative stress with aging in mice. Aging Cell 15:3 (2016), 522–530.
49. + repletion improves mitochondrial and stem cell function and enhances life span in mice. Science 352:6292 (2016), 1436–1443.
50. Braidy, N., Guillemin, G.J., Mansour, H., Chan-Ling, T., Poljak, A., Grant, R., Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in Wistar rats. PLoS One, 6(4), 2011, e19194.
51. + repletion improves muscle function in muscular dystrophy and counters global PARylation. Science Translational Medicine, 8(361), 2016 361ra139-361ra139.
52. Lee, S.J., Choi, S.E., Jung, I.R., Lee, K.W., Kang, Y., Protective effect of nicotinamide on high glucose/palmitate-induced glucolipotoxicity to INS-1 beta cells is attributed to its inhibitory activity to sirtuins. Archives of Biochemistry and Biophysics 535:2 (2013), 187–196.
53. Frederick, D.W., Davis, J.G., Davila, A. Jr., Agarwal, B., Michan, S., Puchowicz, M.A., et al. Increasing NAD synthesis in muscle via nicotinamide phosphoribosyltransferase is not sufficient to promote oxidative metabolism. Journal of Biological Chemistry 290:3 (2015), 1546–1558.
54. Jing, E., O'Neill, B.T., Rardin, M.J., Kleinridders, A., Ilkeyeva, O.R., Ussar, S., et al. Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation. Diabetes 62:10 (2013), 3404–3417.
55. Dolle, C., Skoge, R.H., Vanlinden, M.R., Ziegler, M., NAD biosynthesis in humans–enzymes, metabolites and therapeutic aspects. Current Topics in Medicinal Chemistry 13:23 (2013), 2907–2917.
56. Bai, P., Cantó, C., Oudart, H., Brunyánszki, A., Cen, Y., Thomas, C., et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metabolism 13:4 (2011), 461–468.
57. Mohamed, J.S., Hajira, A., Pardo, P.S., Boriek, A.M., MicroRNA-149 inhibits PARP-2 and promotes mitochondrial biogenesis via SIRT-1/PGC-1alpha network in skeletal muscle. Diabetes 63:5 (2014), 1546–1559.
58. Pirinen, E., Canto, C., Jo, Y.S., Morato, L., Zhang, H., Menzies, K.J., et al. Pharmacological inhibition of poly(ADP-ribose) polymerases improves fitness and mitochondrial function in skeletal muscle. Cell Metabolism 19:6 (2014), 1034–1041.
59. Brown, K.D., Maqsood, S., Huang, J.Y., Pan, Y., Harkcom, W., Li, W., et al. Activation of SIRT3 by the NAD(+) precursor nicotinamide riboside protects from noise-induced hearing loss. Cell Metabolism 20:6 (2014), 1059–1068.
60. Long, A.N., Owens, K., Schlappal, A.E., Kristian, T., Fishman, P.S., Schuh, R.A., Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model. BMC Neurology, 15, 2015, 19.
61. Revollo, J.R., Korner, A., Mills, K.F., Satoh, A., Wang, T., Garten, A., et al. Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metabolism 6:5 (2007), 363–375.
62. Ramsey, K.M., Mills, K.F., Satoh, A., Imai, S., Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice. Aging Cell 7:1 (2008), 78–88.
63. Caton, P.W., Kieswich, J., Yaqoob, M.M., Holness, M.J., Sugden, M.C., Nicotinamide mononucleotide protects against pro-inflammatory cytokine-mediated impairment of mouse islet function. Diabetologia 54:12 (2011), 3083–3092.
64. + binding pocket that regulates protein-protein interactions during aging. Science 355:6331 (2017), 1312–1317.
65. Sasaki, Y., Araki, T., Milbrandt, J., Stimulation of nicotinamide adenine dinucleotide biosynthetic pathways delays axonal degeneration after axotomy. The Journal of Neuroscience 26:33 (2006), 8484–8491.
66. Aguilar, C.A., Shcherbina, A., Ricke, D.O., Pop, R., Carrigan, C.T., Gifford, C.A., et al. In vivo monitoring of transcriptional dynamics after lower-limb muscle injury enables quantitative classification of healing. Scientific Reports, 5, 2015, 13885.
67. Xu, W., Barrientos, T., Mao, L., Rockman, H.A., Sauve, A.A., Andrews, N.C., Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Reports 13:3 (2015), 533–545.